Skip to main content
Figure 1 | BMC Gastroenterology

Figure 1

From: Inhibition of gastric H,K-ATPase activity and gastric epithelial cell IL-8 secretion by the pyrrolizine derivative ML 3000

Figure 1

Dose-dependent inhibition of H,K-ATPase activity by ML 3000 (A) and by omeprazole (B). (A). Gastric microsomes suspended in ATPase assay buffer at pH 7.4 were incubated for 30 min with varying concentrations of ML 3000 and ATPase activity was then measured at pH 7.4. The half-maximal inhibitory concentration (IC50) for ML 3000 was 16.4 μM (CI = 6.84–39.3 μM). (B). Gastric microsomes suspended in ATPase assay buffer at pH 6.1 were incubated for 30 min with varying concentrations of omeprazole, and then transfered to standard ATPase assay buffer at pH 7.4 for ATPase activity measurement. The IC50 for omeprazole was 1.1 μM (CI = 0.26 – 11.3 μM). The data-points show mean ± s.e. from three independent assays in each of which SCH28080-sensitive ATPase activity was measured in triplicate.

Back to article page